Employers grew more concerned about the high cost of pharmaceutical drugs last year, even as the White House rolled out a series of policies intended to lower prices of some popular medications. Nearly three-quarters of employers said they were moderately, very, or extremely concerned about pharmacy costs being “unsustainable” in 2025, according to a recent report from NFP, a benefits consultancy that’s part of Aon. That’s up from 67% who expressed moderate to extreme concern about pharmacy costs in 2024. The growing focus on pharmacy spending comes as employer health costs are projected to rise more than 9% this year, driven in part by coverage of costly GLP-1 medications for weight loss. Managing GLP-1 spending has become a strategy of its own, according to one NFP leader, who advocated for collaboration among CHROs, CFOs, and corporate boards to address this issue. For more on how HR is seeking to control prescription drug spend, keep reading here.—CV |